- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06307496
VIDeOS for Smoking Cessation
September 10, 2025 updated by: Kinsey Pebley, Medical University of South Carolina
Video Interventions for Dependence On Smoking (VIDeOS) for Cancer Patients: A Randomized Controlled Pilot Study
The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video.
Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled pilot study is being conducted to test the acceptability and feasibility of a smoking cessation intervention tailored for cancer patients that is delivered via video.
Participants will be in a video intervention or control group that receives information about quitting smoking.
Participants will complete surveys prior to randomization, and will complete additional surveys one week, one month, and three months post-randomization to provide their thoughts about the videos, information about changes to smoking behaviors, and knowledge about quitting smoking.
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 or older
- Diagnosed with cancer (any type)
- Receiving care at Medical University of South Carolina
- Reads and understands English language
- Currently smoking cigarettes (any amount)
Exclusion Criteria:
- Unstable or poorly managed medical or psychiatric conditions that impair cognition and ability to provide informed consent (e.g., dementia, active psychosis).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Videos
Participants will be sent links to smoking cessation videos to watch.
|
Receive links to smoking cessation videos
|
|
Active Comparator: NCI Pamphlet
Participants will be sent links to NCI's "Clearing the Air" to read.
|
Receive NCI's "Clearing the Air" booklet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: 1 week post-randomization
|
Acceptability will be measured using the Acceptability of Intervention measure, which contains four items with answer options on a scale from 1-5, with higher scores indicating higher acceptability.
We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.
|
1 week post-randomization
|
|
Feasibility
Time Frame: 1 week post-randomization
|
Feasibility will be measured using the Feasibility of Intervention measure, which contains four items with answer options on a scale from 1-5, with higher scores indicating higher feasibility.
We will consider the intervention "feasible" if an average score of 4 or higher is obtained.
|
1 week post-randomization
|
|
Retention Rates
Time Frame: 1 week, 1 month, and 3 months post-randomization
|
We will determine if there are differences in retention rates between intervention groups.
|
1 week, 1 month, and 3 months post-randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in knowledge about quitting smoking
Time Frame: Baseline, 1 week, 1 month, and 3 months post-randomization
|
We will assess changes in knowledge about tools to quit smoking and the role of nicotine, etc. from prior to randomization (before the intervention is delivered) to post-randomization follow-ups.
These questions will be generated by the study investigators based on video content.
|
Baseline, 1 week, 1 month, and 3 months post-randomization
|
|
Changes in smoking behaviors
Time Frame: 1 week, 1 month, and 3 months post-randomization
|
We will assess the number of 24-hour quit attempts and 7-day point prevalence at 1 week, 1 month, and 3 month follow-ups.
|
1 week, 1 month, and 3 months post-randomization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 24, 2024
Primary Completion (Actual)
September 10, 2025
Study Completion (Actual)
September 10, 2025
Study Registration Dates
First Submitted
March 5, 2024
First Submitted That Met QC Criteria
March 11, 2024
First Posted (Actual)
March 12, 2024
Study Record Updates
Last Update Posted (Estimated)
September 16, 2025
Last Update Submitted That Met QC Criteria
September 10, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00133913
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on Smoking cessation intervention
-
University of TennesseeNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Smoker | Cigarette Smoker | Currently Living With SmokerUnited States
-
Pradeesh SivapalanWithdrawnSmoking Cessation | Lung Diseases, Obstructive | Chronic Obstructive Pulmonary Disease | Pulmonary Disease, Chronic ObstructiveDenmark
-
Brigham and Women's HospitalNational Cancer Institute (NCI)CompletedTobacco Use DisorderUnited States
-
University of WaterlooOttawa Heart Institute Research Corporation; Canadian Tobacco Control Research...CompletedSmoking Cessation
-
Kaiser PermanenteCompletedTobacco Use Disorder | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of UtahPatient-Centered Outcomes Research InstituteActive, not recruitingTobacco Use | Tobacco Smoking | Current SmokerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Every Day Smoker | Cigarette SmokerUnited States
-
Unity Health TorontoRecruitingSmoking Cessation | Chronic Obstructive Pulmonary Disease (COPD)Canada
-
Louisiana State University Health Sciences Center...National Institute on Minority Health and Health Disparities (NIMHD)RecruitingMultilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansSmoking Cessation | Tobacco Use Disorder | Lung Cancer ScreeningUnited States